The Ethics of End-of-Trial Obligations in a Pediatric Malaria Vaccine Trial: The Perspectives of Stakeholders From Ghana and Tanzania
JournalArticle (Originalarbeit in einer wissenschaftlichen Zeitschrift)
 
ID 4488785
Author(s) Ward, Claire Leonie; Shaw, David; Anane-Sarpong, Evelyn; Sankoh, Osman; Tanner, Marcel; Elger, Bernice S.
Author(s) at UniBasel Shaw, David
Ward, Claire Leonie
Anane-Sarpong, Evelyn
Tanner, Marcel
Year 2018
Title The Ethics of End-of-Trial Obligations in a Pediatric Malaria Vaccine Trial: The Perspectives of Stakeholders From Ghana and Tanzania
Journal Journal of Empirical Research on Human Research Ethics
Volume 13
Number 3
Pages / Article-Number 258-269
Abstract This study explores stakeholder experiences and perspectives on end-of-trial obligations at the close of a phase II/III Pediatric Malaria Vaccine Trial (PMVT) [GSK/PATH-MVI RTS, S) ( NCT00866619 ]. We conducted 52 key informant interviews with major stakeholders of an international multicentre PMVT in Ghana and Tanzania. The responses fell into four main themes: (a) Communicating End-of-Trial, (b) Maintaining Health Care Services, (c) Dissemination of Results, and (d) Post-Trial Access. Interviewee responses shared important practical experiences and insights that complement current thinking in the literature on research ethics guidance: (a) accompany end-of-trial communication with information on personal and family health care responsibilities, (b) establish public health indicators to measure the impact of research on a health care system.
Publisher SAGE
ISSN/ISBN 1556-2646 ; 1556-2654
edoc-URL https://edoc.unibas.ch/73965/
Full Text on edoc No
Digital Object Identifier DOI 10.1177/1556264618771809
PubMed ID http://www.ncbi.nlm.nih.gov/pubmed/29756531
ISI-Number WOS:000434701800006
Document type (ISI) Article
 
   

MCSS v5.8 PRO. 0.460 sec, queries - 0.000 sec ©Universität Basel  |  Impressum   |    
16/05/2022